To evaluate the cost/efficacy of b-lactam/b-lactamase inhibitor combinations
- At: 2004 FIP Congress in New Orleans (USA)
- Type: Poster
- By: WANG (Tainan Municipal Hospital, pharmacy, Tainan, China Taiwan)
- Co-author(s): Huang (Tainan municipal hospital, China Taiwan)
Hsu (Tainan municipal hospital, China Taiwan)
Introduction: Bacteria resistance to b-lactam antibiotics has been well documented. Currently, the use of b-lactamase inhibitors is the most successful strategy to restore the efficacy of b-lactam antibiotics. The Tazocin and Pipril are coexisted in our hospital. The aim of this study was to compare the difference of the cost/efficacy between.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.